14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 3.047 3 days ( -4.76 % )
Last Price $0.110 4.76 %
High/ Low $0.102 - $0.110 9.80%
Chg 7 Days N/A $0.110 $0.110
Chg 30 Days 10.00 % $0.100 $0.110
Chg 12 mos 100.00 % $0.0550 $0.110
Trend - 3 mos 27.06 % Width: 24.97 %
Trend - 12 mos 72.78 % Width: 40.70 %
Pred. range - 3 mos $0.129 - $0.161 17.04 % - 46.27 %
Pred. range - 12 mos $0.151 - $0.213 37.41 % - 93.34 %
Short MA avg 3 mos Sell Jun 11, 2024 - 5 days
Long MA avg 3 mos Sell Jun 11, 2024 - 5 days
Short/Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short MA avg 12 mos Buy Jun 14, 2024 - 2 days
Long MA avg 12 mos Sell Apr 05, 2024 - 50 days
Short/Long MA avg 12 mos Buy Apr 17, 2024 - 42 days
Pivot Short Sell May 23, 2024 - 17 days
Bollinger Buy May 06, 2024 - 30 days
MACD Sell No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About Phylogica Limited

Phylogica Limited PYC Therapeutics Limited, a development-stage biotechnology company, engages in the discovery and development of drug solutions in the areas of ribonucleic acid therapeutics in Australia. The company's preclinical development programs include VP-001, drug program for retinitis pigmentosa type 11; and VP-002, a drug program for the treatment of autosomal dominant optic atrophy. It also focuses on the development of programs for retinal and central... PYC.AX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT